Durham, NC, United States of America

Pam Golden

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Pam Golden: Innovator in Pharmaceutical Sciences

Introduction

Pam Golden is a distinguished inventor based in Durham, NC (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of solid dispersion forms of rifaximin. With a total of 9 patents to her name, her work has had a profound impact on drug formulation and delivery.

Latest Patents

Among her latest patents, Pam Golden has developed solid dispersions comprising rifaximin and pharmaceutical compositions. These innovations are crucial for enhancing the solubility and bioavailability of rifaximin, a medication used to treat various gastrointestinal conditions. The details of her patents highlight the importance of her work in improving patient outcomes through advanced pharmaceutical formulations.

Career Highlights

Throughout her career, Pam has worked with notable companies in the pharmaceutical industry, including Salix Pharmaceuticals, Inc. and Alfa Wassermann S.p.a. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research and development in drug formulation.

Collaborations

Pam has collaborated with esteemed colleagues such as Mohammed A Kabir and Giuseppe Claudio Viscomi. These partnerships have fostered innovation and have been instrumental in advancing her research initiatives.

Conclusion

Pam Golden's contributions to pharmaceutical sciences through her patents and collaborations underscore her role as a leading inventor in the field. Her work continues to influence the development of effective drug formulations, benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…